ARTICLE | Company News
Vyrex, National Institute of Neurological Disorders and Stroke other research news
August 19, 2002 7:00 AM UTC
VYRX signed a CRADA with the institute to study the use of Panavir to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage (SAH). SAH typically is caused by the rupture of ...